US Physical Therapy (USPH) Taps A Global Finance Veteran As CFO
US Physical Therapy (USPH) appointed Nchacha Etta as CFO, effective September 1. Etta previously held CFO roles at Omnicell (OMCL) and Johnson & Johnson Vision. USPH reported Q2 2026 revenue of $214.1M, up 8.5%, but net income fell to $9.9M from $12.4M. The company reaffirmed full-year adjusted EBITDA guidance of $102M-$106M.
How this was made
The 30-second read
Why it matters
Traders may reassess execution risk around acquisitions and hospital partnerships as the company reports margin compression, lower net income/EPS, declining cash, and higher credit-facility borrowings, despite reaffirming 2026 adjusted EBITDA guidance.
Market read
A permanent CFO appointment is paired with disclosed financial deterioration (margin, EPS, cash) and rising leverage, creating a near-term narrative test for back-half EBITDA acceleration.
What to watch
Integration of remaining hospital-affiliated clinics and the April refinancing terms could matter more than the CFO identity for near-term leverage and earnings quality.
Background
US Physical Therapy had an interim CFO (Jason Curtis) starting April 24 after a search began, and it is now appointing Nchacha Etta as permanent CFO effective Sept. 1.
Ticker impact
US Physical Therapy names Nchacha Etta as CFO effective Sept. 1, ending an interim period and coinciding with margin pressure and reaffirmed 2026 EBITDA guidance.
Likely modest, with traders focusing on whether Etta can stabilize margins and manage integration while leverage rises.
The article provides a concrete executive change plus specific financial headwinds (EPS decline, margin down, cash down, borrowings up) and a reaffirmed EBITDA outlook, which can shift expectations for back-half execution.
Market effects
May influence investor confidence in outpatient therapy operators’ ability to manage benefit-cost inflation and integration economics.
No specific regional impact described.
Limited, as the event is company-specific and US-focused.
Counterpoint
The CFO hire may be more about continuity than a turnaround catalyst, so the stock reaction could fade if margins and cash burn do not improve.
Key entities
- public_companyUS Physical Therapy
Outpatient physical therapy operator appointing a new CFO amid margin pressure and reaffirmed 2026 EBITDA guidance.
- executiveNchacha Etta
Incoming CFO, previously CFO roles at Omnicell, Essilor of America, and J&J Vision.
- executiveJason Curtis
Interim CFO whose tenure is ending with the permanent CFO appointment.
